Skip to main content

Search Results

Displaying: 1 - 10 of 23 Results

Ionic liquid aerosols for respiratory complications related to COVID-19

Researchers in the lab of Samir Mitragotri have developed ionic liquid aerosols that have the potential to combat pulmonary bacterial infections. The technology may help to treat the respiratory conditions resulting from COVID-19 infection and…

Investigators

  • Samir Mitragotri

Compounds that block human cytomegalovirus by targeting the nuclear egress complex

Researchers in Dr. Donald Coen’s lab have identified molecules that inhibit human cytomegalovirus (HCMV) virion egress from the cell, effectively inhibiting HCMV replication. The team is looking to expand on these findings in collaborations that…

Investigators

  • Donald Coen

Novel annulation catalysts via direct C-H bond amination

Introducing functionality into unactivated C-H bonds, a ubiquitous group in organic molecules, remains a significant challenge due to the inertness of the substrate. Traditional synthesis strategies involve functional group exchange, an inefficient…

Investigators

  • Theodore Betley
  • Elisabeth Hennessy
  • Alexandre Mikhailine
  • Claudia Kleinlein
  • Yuyang Dong
  • Yunjung Baek

Polymixin synergistic novobiocin analogs for efficacious and safer treatment of Gram negative infections

The lipopolysaccharide (LPS) containing outer membrane of Gram-negative bacteria prevent penetration of antibiotics, making them ineffective against infections. Polymyxins, including colistin, bind LPS and disrupt the outer membrane and hence are…

Investigators

  • Daniel Kahne

Stapled peptide that inhibits bacterial transporter

Multidrug-resistant infection has become a worldwide epidemic in recent years especially in hospitals and other community-associated settings, causing great suffering of patients and huge healthcare burden. According to CDC, at least 23,000 people…

Investigators

  • Martin Karplus

Method for large-scale production of differentiated neurons

INTRODUCTIONHuman pluripotent stem cells (hPSC’s) can be used to generate a wide variety of somatic cell types. In addition, they can be grown in large numbers and thus can be a tractable source for cell types that are otherwise difficult to…

Investigators

  • Lee Rubin

Novel antibiotics against Gram-negative and drug-resistant bacterial pathogens

Dr. Kahne has a pipeline of programs aimed at developing first-in-class antibiotics:Program I: Potentiator of polymixin, increasing its therapeutic index for treatment of drug-resistant infectionsIn vitro: Novel agent potentiates activity of…

Investigators

  • Daniel Kahne

SIM-PAL: proteome wide identification of small molecule binding sites

Precise target identification for small molecules is an important and essential step in drug development. Despite its importance, there are very few unbiased, proteome-wide approaches aimed at identifying binding partners for small molecules. In…

Investigators

  • Christina Woo

Small molecule inhibitors of Zika, dengue and other flaviviruses

Currently, broadly-protective antivirals targeting flaviviruses such as Zika, Dengue and West Nile viruses, are not available. Researchers in the laboratory of Dr. Priscilla Yang have identified a group of small molecules, including a prototype…

Investigators

  • Priscilla Yang

Targeting spiral ganglion neurons for treatment of hearing loss

Hearing loss makes interactions with the world challenging for over 30 million people in the United States. While cochlear implants and hearing aid devices can ameliorate hearing loss, they often fail to restore the function of spiral ganglion…

Investigators

  • Lisa Goodrich

Page 1 of 3